National Comprehensive Cancer Network



About NCCN

Bone Cancer Panel - Disclosures as of 4/17/2015

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Douglas R. Adkins, MD

Amgen Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Eisai Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Threshold Pharmaceuticals;
Pfizer Inc.

None

None

None

None

2/11/2015

Mark Agulnik, MD

None

None

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

None

None

2/11/2015

Robert S. Benjamin, MD

Johnson & Johnson;
Immune Design

None

None

None

Johnson & Johnson;
Merck & Co., Inc.;
Pfizer Inc.

9/5/2014

Mary Anne Bergman

None

None

None

None

None

4/9/2015

J. Sybil Biermann, MD

None

None

None

None

None

3/25/2015

Marian Birkeland, PhD

None

None

None

None

None

4/13/2015

Brian Brigman, MD, PhD

Illuminoss;
Lumicell Diagnostics;
Musculoskeletal Transplant Foundation;
PARITY Research Trial;
Plexxicon

Musculoskeletal Transplant Foundation

Musculoskeletal Transplant Foundation

None

None

3/18/2015

Warren Chow, MD, FACP

Eli Lilly and Company;
Eli Lilly and Company;
GlaxoSmithKline;
GlaxoSmithKline;
CytRX;
CytRX;
Immunex;
Immunex;
NCCN;
NCCN;
SARC;
SARC

None

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation

None

None

2/11/2015

William T. Curry, MD

None

None

None

None

None

3/29/2012

Nicola Fabbri, MD

Memorial Sloan Kettering Cancer Center

None

None

None

None

2/22/2015

Fayna Ferkle, PharmD

None

None

None

None

None

4/9/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

4/15/2015

Kenneth R. Hande, MD

None

None

None

None

None

3/31/2015

Francis J. Hornicek, MD, PhD

None

AO Spine;
Stryker Corporation

None

None

None

6/17/2013

Anna Kulidjian, MD, MSc, FRCSC

Novartis Pharmaceuticals Corporation

None

None

None

None

9/19/2013

Dieter Lindskog, MD

None

Merck & Co., Inc.

None

None

None

3/23/2015

Joel Mayerson, MD

Millennium Pharmaceuticals, Inc.

None

None

None

None

2/11/2015

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Sean V. McGarry, MD

None

DePuy/Synthes;
Musculoskeletal Transplant Foundation

None

None

None

2/11/2015

Brian McGrath, MD

None

None

None

None

None

12/16/2009

Lynn Million, MD

None

None

None

None

None

3/24/2015

Carol D. Morris, MD, MS

None

None

None

None

None

4/1/2015

Sujana Movva, MD

None

None

None

None

None

2/11/2015

Richard J. O'Donnell, MD

None

None

None

None

None

9/3/2014

Donna Powell, MS, CMD, RT(T)

None

None

None

None

None

4/6/2015

R. Lor Randall, MD, FACS

Children`s Oncology Group;
Connective tissue Oncology Society;
Musculoskeletal Tumor Society

Alan B. Slifka Foundation;
Biomet;
International Society of Paediatric Oncology;
Musculoskeletal Transplant Foundation;
Sarcoma Foundation of America

Biomet;
Musculoskeletal Transplant Foundation

Association of Bone and Joint Surgeons

None

2/19/2015

Damon R. Reed, MD

None

Advaxis;
EMD Serrano

None

None

None

1/14/2015

Peter Rose, MD

PARITY Trial (RCT of antibiotic regimens in tumor surgery)

None

None

None

None

9/28/2014

Victor M. Santana, MD

Novartis Pharmaceuticals Corporation

None

None

None

None

4/10/2015

Robert L. Satcher, MD, PhD

None

None

None

None

None

2/11/2015

Jillian L. Scavone, PhD

None

None

None

None

None

11/7/2014

Herrick J. Siegel, MD

None

None

None

None

None

8/19/2012

Victor Villalobos, MD, PhD

Eli Lilly and Company

Janssen Pharmaceutica Products

None

None

None

4/6/2015